Cargando…

Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic

OBJECTION: The psychological health of thyroid cancer patients cannot be ignored; however, few studies have been conducted on the psychological status and influencing factors of thyroid cancer patients before radioactive iodine (RAI) therapy. The aim of this study was to investigate the incidence an...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Tingting, Gao, Dingwei, Tong, Junyu, Shen, Yun, Ma, Jiayue, Lv, Zhongwei, Li, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631608/
https://www.ncbi.nlm.nih.gov/pubmed/36326909
http://dx.doi.org/10.1007/s00520-022-07422-7
_version_ 1784823850461036544
author Qiao, Tingting
Gao, Dingwei
Tong, Junyu
Shen, Yun
Ma, Jiayue
Lv, Zhongwei
Li, Dan
author_facet Qiao, Tingting
Gao, Dingwei
Tong, Junyu
Shen, Yun
Ma, Jiayue
Lv, Zhongwei
Li, Dan
author_sort Qiao, Tingting
collection PubMed
description OBJECTION: The psychological health of thyroid cancer patients cannot be ignored; however, few studies have been conducted on the psychological status and influencing factors of thyroid cancer patients before radioactive iodine (RAI) therapy. The aim of this study was to investigate the incidence and risk factors for anxiety and depression in thyroid cancer patients prior to RAI therapy. METHODS: Clinical data were collected from patients with differentiated thyroid cancer (DTC) patients preparing for RAI therapy. Anxiety and depression were measured before RAI therapy using the Generalized Anxiety Disorder Questionnaire (GAD-7) and Patient Health Questionnaire (PHQ-9). We used the chi-square test and logistic regression analysis to identify independent risk factors for anxiety and depression. RESULTS: A total of 112 patients with thyroid cancer were included. Of these, 72.32% (n = 81) were female, with a mean age of 41.50 years. Anxiety and depression were reported by 46 (41.08%) and 38 (33.93%) patients, respectively. Based on the chi-square test and univariate logistic regression analysis, being female and having ever-experienced RAI therapy were significant risk factors for anxiety and depression among DTCs prior to RAI therapy. On multivariable analysis, the results of model 2 which included age, sex, education level, and ever suffering radioactive iodine therapy showed that being female was markedly associated with anxiety and depression in these patients, while having ever undergone RAI therapy was significantly related to anxiety but not depression. CONCLUSIONS: The incidence of anxiety and depression among patients with DTC prior to RAI therapy were 41.08% and 33.93%, respectively. Being female and having ever experienced RAI therapy significantly influenced anxiety and depression. Based on these findings, anxiety and depression assessment should be an important part of pre-RAI therapy in patients with DTC, and appropriate psychological nursing intervention can be carried out for key patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-022-07422-7.
format Online
Article
Text
id pubmed-9631608
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96316082022-11-03 Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic Qiao, Tingting Gao, Dingwei Tong, Junyu Shen, Yun Ma, Jiayue Lv, Zhongwei Li, Dan Support Care Cancer Research OBJECTION: The psychological health of thyroid cancer patients cannot be ignored; however, few studies have been conducted on the psychological status and influencing factors of thyroid cancer patients before radioactive iodine (RAI) therapy. The aim of this study was to investigate the incidence and risk factors for anxiety and depression in thyroid cancer patients prior to RAI therapy. METHODS: Clinical data were collected from patients with differentiated thyroid cancer (DTC) patients preparing for RAI therapy. Anxiety and depression were measured before RAI therapy using the Generalized Anxiety Disorder Questionnaire (GAD-7) and Patient Health Questionnaire (PHQ-9). We used the chi-square test and logistic regression analysis to identify independent risk factors for anxiety and depression. RESULTS: A total of 112 patients with thyroid cancer were included. Of these, 72.32% (n = 81) were female, with a mean age of 41.50 years. Anxiety and depression were reported by 46 (41.08%) and 38 (33.93%) patients, respectively. Based on the chi-square test and univariate logistic regression analysis, being female and having ever-experienced RAI therapy were significant risk factors for anxiety and depression among DTCs prior to RAI therapy. On multivariable analysis, the results of model 2 which included age, sex, education level, and ever suffering radioactive iodine therapy showed that being female was markedly associated with anxiety and depression in these patients, while having ever undergone RAI therapy was significantly related to anxiety but not depression. CONCLUSIONS: The incidence of anxiety and depression among patients with DTC prior to RAI therapy were 41.08% and 33.93%, respectively. Being female and having ever experienced RAI therapy significantly influenced anxiety and depression. Based on these findings, anxiety and depression assessment should be an important part of pre-RAI therapy in patients with DTC, and appropriate psychological nursing intervention can be carried out for key patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-022-07422-7. Springer Berlin Heidelberg 2022-11-03 2022 /pmc/articles/PMC9631608/ /pubmed/36326909 http://dx.doi.org/10.1007/s00520-022-07422-7 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research
Qiao, Tingting
Gao, Dingwei
Tong, Junyu
Shen, Yun
Ma, Jiayue
Lv, Zhongwei
Li, Dan
Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
title Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
title_full Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
title_fullStr Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
title_full_unstemmed Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
title_short Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
title_sort anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the covid‑19 pandemic
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631608/
https://www.ncbi.nlm.nih.gov/pubmed/36326909
http://dx.doi.org/10.1007/s00520-022-07422-7
work_keys_str_mv AT qiaotingting anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic
AT gaodingwei anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic
AT tongjunyu anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic
AT shenyun anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic
AT majiayue anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic
AT lvzhongwei anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic
AT lidan anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic